The high molecular weight insulin-like growth factor-binding protein complex: Epitope mapping, immunoassay, and preliminary clinical evaluation

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 8, 1999, Pages 2826-2833

  Khosravi, Javad ^a,b,d   Diamandi, Anastasia ^a   Mistry, Jehangir ^c   Krishna, Radha G ^c  

^a Diagnostic Systems Laboratories   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c Diagnostic Systems Laboratories Inc   (United States)

^d MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GROWTH HORMONE RECEPTOR; MONOCLONAL ANTIBODY; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ACROMEGALY; ADOLESCENT; ADULT; ARTICLE; CELL GROWTH; CELL METABOLISM; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; EPITOPE MAPPING; FEMALE; GROWTH HORMONE DEFICIENCY; HUMAN; IMMUNOASSAY; MALE; PRIORITY JOURNAL; PROTEIN BINDING;

EID: 0033323805     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.84.8.5914     Document Type: Article

References (41)

1. Structure, evolution, expression and regulation of insulin-like growth factors I and II [Review]
2. Insulin-like growth factors, and their receptors as growth regulators in normal physiology and pathological states [Review]
3. Insulin-like growth factors and their binding proteins: Biological actions [Review]
4. Insulin-like growth factor-binding proteins in serum and other biological fluids: Regulation and functions [Review]
5. Insulin-like growth factor-binding proteins [Review]
6. Insulin-like growth factor binding proteins: Structural and molecular relationships [Review]
7. Physiologic and clinical relevance of the insulin-like growth factor binding proteins [Review]
8. 125I]IGF-I
9. Structure of the Mr 140,000 growth factor binding protein complex: Determination by reconstitution and affinity labeling
10. High molecular weight insulin-like growth factor binding protein complex. Purification properties of the acid-labile subunit from human serum
11. Acid-labile subunit of human insulin-like growth factor binding protein complex: Measurement, molecular and clinical evaluation
12. Editorial: The binding protein's binding protein- clinical applications of acid-labile subunit (ALS) measurement
13. Assays of insulin-like growth factors and their binding proteins: Praticalities and pitfalls
14. A non-competitive ELISA for human serum insulin-like growth factor-I
15. Clinical utility of insulin-like growth factor assays [Review]
16. Active insulin-like growth factor-I (IGF-I) assays
17. Serum somatomedin levels in adults with chronic renal failure: The importance of measuring insulin-like growth factor-I (IGF-I) and IGF-II in acid-chromatographed uremic serum
18. Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites: A comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol-extracted serum
19. A specific radioimmunoassay for insulin-like growth factor II: The interference of IGF binding proteins can be blocked by excess IGF-I
20. Comparison of acid-ethanol extraction, and acid-gel filtration prior to IGF-I and IGF-II radioimmunoassays: Improvement of determinations in acid-ethanol extracts by the use of truncated IGF-I as radioligand
21. Failure of acid-ethanol treatment to prevent interference by binding proteins in radioligand assays for insulin-like growth factors
22. Radioimmunoassay for insulin-like growth factor-I: Solutions to some potential problems and pitfalls
23. Serum somatomedin binding proteins: Physiologic significance and interference in radioligand assay
24. 18 Sep-Pak separation
25. Specificity of new immunoassays for human insulin-like growth factor (IGF) binding protein-3 (IGFBP-3) [Abstract]
26. Measurement of the acid-labile subunit of insulin-like growth factor binding protein complex in human serum: A comparison of four immunoassays
27. Diagnostic controversy: The diagnosis of childhood growth hormone deficiency revisited
28. Editorial: Is growth hormone deficiency a viable diagnosis
29. Biochemical tests in the diagnosis of childhood growth hormone deficiency
30. Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment
31. Serum insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3 and the acid-labile subunit as serum markers of body composition during growth hormone (GH) therapy in adults with GH deficiency
32. Monitoring of growth hormone replacement therapy in adults based on measurement of serum markers
33. Circulating levels and molecular distribution of the acid-labile subunit of the high molecular weight insulin-like growth factor binding protein complex
34. Filter paper blood spot assay of human insulin-like growth factor I (IGF-I) and IGF-binding protein-3 and preliminary application in the evaluation of growth hormone status
35. Ultrasensitive immunoassay for prostate-specific antigen based on conventional colorimetric detection
36. Synthesis of IGFBP-3 fragments in a baculovirus system and characterization of monoclonal anti-IGFBP-3 antibodies
37. Immunofluorometry of choriogonadotropin by time-resolved fluorescence spectroscopy, with a new europium chelate as label
38. Development of a non-competitive immunoenzymometric assay for human insulin-like growth factor-II in serum
39. A non-competitive immunoenzymatic assay for insulin-like growth factor binding protein-3 in serum
40. IGFBP-3 proteolysis by plasmin, thrombin, serum: Heparin binding, IGF binding, and structure of fragments
41. Functional epitope mapping of insulin-like growth factor I (IGF-I) by anti-IGF monoclonal antibodies